Clinical Trial Update: The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating penpulimab for metastatic pheochromocytoma/paraganglioma after failure of prior systemic treatments.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paraganglioma Malignant
• Pheochromocytoma
• Pheochromocytoma Malignant

Drugs mentioned

• Penpulimab

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Pheochromocytoma, Metastatic, Pheochromocytoma Malignant | Phase 2 | Status: UNKNOWN